The resulting multi-dimensional data can be processed with artificial intelligence systems to develop prediction algorithms and decision support systems with the aim of improving glucose control, safety, and quality of life of PBH patients
Clinicians should reassess treatment efficacy after approximately 3-6 months on a maintenance dose, as recommended by clinical guidelines
Handling Side Effects Common side effects of Zepbound and Wegovy may include gastrointestinal discomfort, nausea, vomiting, diarrhea, or constipation
If nausea or lack of appetite makes solid food unappealing, a protein shake may be the best option
But they dont occur in a majority of patients and they often dissipate with ongoing use
Patients who completed a full course of semaglutide or tirzepatide and achieved meaningful weight loss but not enough, or hit a plateau before reaching a healthy body composition are exactly the population the TRIUMPH trial data speaks to